-- 周四下午晚些时候，金融股上涨，纽约证券交易所金融指数上涨0.3%，道富金融精选行业SPDR ETF（XLF）上涨0.4%。 费城住房指数上涨1.2%，道富房地产精选行业SPDR ETF（XLRE）上涨0.8%。 比特币（BTC-USD）上涨1.1%至72,174美元，10年期美国国债收益率小幅走低至4.29%。 经济方面，美国第四季度经济增长率（以国内生产总值衡量）从第二次预估值的0.7%下调至0.5%，而彭博社调查的预期则为不变。 截至4月4日当周，美国首次申请失业救济人数升至21.9万人，高于前一周向上修正后的20.3万人，而彭博社此前调查的预期为21万人。 公司新闻方面，Ares Management (ARES) 周四同意以约17亿美元的全现金交易收购Whitestone REIT (WSR)。Ares股价小幅下跌，而Whitestone股价上涨近12%。 据《华尔街日报》援引一封股东信报道，凯雷集团(CG)在收到约占流通股15.7%的回购请求后，将把旗下战术私募信贷基金的赎回比例限制在5%。凯雷集团股价基本持平。 据彭博社报道，高盛(GS)支持的日本网约车服务商Go计划于2026年进行首次公开募股(IPO)，预计募资额在500亿日元（约合3.145亿美元）至800亿日元之间。高盛股价应声下跌0.2%。 据彭博社报道，TPG(TPG)已聘请瑞银(UBS)和马来亚银行(Malayan Banking)协助评估马来西亚医疗服务提供商Asia OneHealthcare的各种方案。TPG股价上涨1.2%，瑞银股价上涨0.3%。
Related Articles
Research
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
$HIG
Research
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
$BKR
Research
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.
$WAB